← All Madrigal Pharmaceuticals, INC filings

Madrigal Pharmaceuticals, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
MDGL
Madrigal Pharmaceuticals, INC
SCHEDULE: Madrigal Pharma Director Amends 7.8% Stake Disclosure
Dr. Rebecca Taub, a director at Madrigal Pharmaceuticals, filed an amended Schedule 13D to update her beneficial ownership, now totaling 7.8% of common stock, and disclose recent share transactions.
NASDAQ
MDGL
Madrigal Pharmaceuticals, INC
SCHEDULE: Madrigal Pharma Director Updates 7.8% Stake
Dr. Paul A. Friedman, a director at Madrigal Pharmaceuticals, Inc., filed an amended Schedule 13D disclosing a 7.8% beneficial ownership stake and recent stock transactions.